GATA3-Driven Th2 Responses Inhibit TGF-β1-Induced FOXP3 Expression And The Formation Of Regulatory T Cells
Main Category: Biology / BiochemistryArticle Date: 26 Dec 2007 - 17:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Immune responses against foreign bodies are driven by specialized T-cells whose numbers expand upon recognition of antigen found on professional antigen-presenting cells. The subsequent maturation process involves the differentiation of certain T-cell phenotypes such as pro-inflammatory cells (Th1, Th2, Th17) or regulatory T-cells (Tregs), which serve to keep the immune response in check. The current study focuses on the role of two key transcription factors, FOXP3 and GATA3, in controlling the commitment of these cells.
Published this week in the open-access journal PLoS Biology, Pierre-Yves Mantel, Carsten Schmidt-Weber, and colleagues demonstrate that the Th2 cytokine IL-4 inhibits the induction of FOXP3 and thus the generation of inducible Tregs. They show that IL-4-induced GATA3 mediates FOXP3-inhibition by directly binding to a GATA-element in the FOXP3 promoter. They also hypothesize that therapeutic agents aimed at neutralizing IL-4 could be a novel strategy to facilitate inducible Treg-generation and thus promotion of tolerance in allergies and other Th2-dominated diseases.
Citation: Mantel PY, Kuipers H, Boyman O, Rhyner C, Ouaked N, et al. (2007) GATA3-driven Th2 responses inhibit TGF-b1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 5(12): e329. doi:10.1371/journal.pbio.0050329
Please click here
http://www.plosbiology.org
Public Library of Science
185 Berry Street, Suite 3100
San Francisco, CA 94107
USA
Visit our biology / biochemistry section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/92521.php>
APA
http://www.medicalnewstoday.com/releases/92521.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



